Immune Checkpoints PVR and PVRL2 Are Prognostic Markers in AML and Their Blockade Represents a New Therapeutic Option
Oncogene - United Kingdom
doi 10.1038/s41388-018-0288-y
Full Text
Open PDFAbstract
Available in full text
Date
May 31, 2018
Authors
Publisher
Springer Science and Business Media LLC